Zhongzhu Medical Holdings Co Ltd (SHG:600568) — Market Cap & Net Worth

$696.97 Million USD · CN¥4.76 Billion CNY · Rank #10741

Market Cap & Net Worth: Zhongzhu Medical Holdings Co Ltd (600568)

Zhongzhu Medical Holdings Co Ltd (SHG:600568) has a market capitalization of $696.97 Million (CN¥4.76 Billion) as of September 24, 2026. Listed on the SHG stock exchange, this China-based company holds position #10741 globally and #2966 in its home market, demonstrating a 1.27% increase in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying Zhongzhu Medical Holdings Co Ltd's stock price CN¥2.39 by its total outstanding shares 1992869681 (1.99 Billion). Also see 600568 total asset value for a full breakdown of the balance sheet.

Zhongzhu Medical Holdings Co Ltd Market Cap History: 2015 to 2026

Zhongzhu Medical Holdings Co Ltd's market capitalization history from 2015 to 2026. Data shows change from $2.45 Billion to $696.97 Million (-8.86% CAGR). Also see cash flow conversion of Zhongzhu Medical Holdings Co Ltd for how efficiently the company converts equity into cash flow.

Zhongzhu Medical Holdings Co Ltd Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how Zhongzhu Medical Holdings Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check Zhongzhu Medical Holdings Co Ltd (600568) stock price for real-time trading data and today's change.

Latest Price to Sales (P/S) Ratio

1.27x

Zhongzhu Medical Holdings Co Ltd's market cap is 1.27 times its annual revenue

Industry average: 0.64x Higher than industry average

Latest Price to Earnings (P/E) Ratio

N/A

P/E ratio not applicable due to negative or zero earnings

What These Ratios Tell Investors:

Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
Industry comparison provides context for whether the company is valued higher or lower than peers.

Year	Market Cap (USD)	Revenue (USD)	Net Income (USD)	P/S Ratio	P/E Ratio
2016	$2.57 Billion	$1.10 Billion	$294.17 Million	2.34x	8.72x
2017	$2.25 Billion	$981.02 Million	$169.34 Million	2.29x	13.29x
2018	$664.89 Million	$572.86 Million	-$1.89 Billion	1.16x	N/A
2019	$510.33 Million	$696.17 Million	-$369.50 Million	0.73x	N/A
2020	$405.35 Million	$727.47 Million	$3.22 Million	0.56x	125.93x
2021	$571.57 Million	$581.06 Million	-$211.28 Million	0.98x	N/A
2022	$548.24 Million	$505.97 Million	-$799.26 Million	1.08x	N/A
2023	$501.59 Million	$638.56 Million	-$343.94 Million	0.79x	N/A
2024	$379.11 Million	$521.39 Million	-$620.22 Million	0.73x	N/A
2025	$731.96 Million	$577.34 Million	-$114.19 Million	1.27x	N/A

Competitor Companies of 600568 by Market Capitalization

Companies near Zhongzhu Medical Holdings Co Ltd in the global market cap rankings as of September 24, 2026. Review Zhongzhu Medical Holdings Co Ltd tangible equity quality to assess the quality of the company's equity after excluding intangible assets.

Key companies related to Zhongzhu Medical Holdings Co Ltd by market ranking:

Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #524 globally with a market cap of $52.60 Billion USD.
GALDERMA GROUP AG (NYSE:GALDY): Ranked #586 globally with a market cap of $46.44 Billion USD.
Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #638 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #651 globally with a market cap of $42.68 Billion USD ( CN¥291.65 Billion CNY).

Market capitalization comparison (in billions USD)

Rank	Company	Symbol	Market Cap	Price
#524	Takeda Pharmaceutical Co Ltd ADR	NYSE:TAK	$52.60 Billion	$16.65
#586	GALDERMA GROUP AG	NYSE:GALDY	$46.44 Billion	$39.83
#638	Takeda Pharmaceutical Company Limited	F:TKDA	$43.60 Billion	€16.50
#651	Jiangsu Hengrui Medicine Co Ltd	SHG:600276	$42.68 Billion	CN¥45.72

Zhongzhu Medical Holdings Co Ltd Historical Marketcap From 2015 to 2026

Between 2015 and today, Zhongzhu Medical Holdings Co Ltd's market cap moved from $2.45 Billion to $ 696.97 Million, with a yearly change of -8.86%.

Year	Market Cap	Change (%)
2026	CN¥696.97 Million	-4.78%
2025	CN¥731.96 Million	+93.08%
2024	CN¥379.11 Million	-24.42%
2023	CN¥501.59 Million	-8.51%
2022	CN¥548.24 Million	-4.08%
2021	CN¥571.57 Million	+41.01%
2020	CN¥405.35 Million	-20.57%
2019	CN¥510.33 Million	-23.25%
2018	CN¥664.89 Million	-70.45%
2017	CN¥2.25 Billion	-12.32%
2016	CN¥2.57 Billion	+4.55%
2015	CN¥2.45 Billion	--

End of Day Market Cap According to Different Sources

On Sep 23rd, 2026 the market cap of Zhongzhu Medical Holdings Co Ltd was reported to be:

Source	Market Cap
Yahoo Finance	$696.97 Million USD
MoneyControl	$696.97 Million USD
MarketWatch	$696.97 Million USD
marketcap.company	$696.97 Million USD
Reuters	$696.97 Million USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.

About Zhongzhu Medical Holdings Co Ltd

SHG:600568 China Drug Manufacturers - Specialty & Generic

Market Cap

$696.97 Million

CN¥4.76 Billion CNY

Market Cap Rank

#10741 Global

#2966 in China

Share Price

CN¥2.39

Change (1 day)

-1.24%

52-Week Range

CN¥1.82 - CN¥3.21

All Time High

CN¥9.91